NX Pro LIMS

NX Pro LIMS is a preconfigured Lab Testing & Research Management System specifically designed for COVID-19 testing and research. This software solution is tailored for clinical research laboratories and diagnostic testing laboratories, targeting clinical researchers, laboratory technicians, healthcare professionals, medical professionals, and pharmaceutical companies.

Key Features

COVID-19 Test Workflow Configuration: According to the vendor, NX Pro LIMS enables clinical test labs to configure FDA approved COVID-19 test workflows, assisting in the development, standardization, and validation of new methods for COVID-19 testing. Test results can be reported in compliance with FDA and CDC guidelines, while the system ensures adherence to CLIA, ISO 15189:2012, HIPAA, and other international regulatory guidelines.

Preconfigured COVID-19 Diagnostic Testing Laboratory Workflow: NX Pro LIMS provides a schematic representation of a preconfigured COVID-19 diagnostic testing laboratory workflow. It includes various steps such as test request receipt, batch accessioning of specimens, specimen processing, RT-PCR testing, result importation to a LIMS, result validation, report submission to FDA & CDC, and proper disposal of specimens.

COVID-19 Diagnostic Test and Research Capabilities: The vendor asserts that NX Pro LIMS is capable of performing various COVID-19 tests, including RT-PCR tests, Rapid Diagnostic Tests (RDT), serological tests for IgG/IgM antibodies, neutralization tests, and ELISA tests. It offers pre-designed workflows and reporting templates to facilitate prompt test results, and can be easily configured to accommodate new test methods and their respective assessment and reporting requirements.

Compliance with Regulatory Guidelines: The vendor states that NX Pro LIMS assists laboratories in adhering to FDA and CDC reporting guidelines while generating customized test reports. It automatically records laboratory activities to maintain a read-only audit trail, enables physicians to enter patient data, track real-time request status, manage specimens and inventory, and provides secure document management for patient-related records.

Protection of Patient Health Information (PHI): According to the vendor, NX Pro LIMS assigns PHI access exclusively to authorized personnel, ensuring the confidentiality of patient data and safeguarding sensitive information from unauthorized access. The system offers staff training and performance monitoring, along with efficient document management for the secure storage and retrieval of patient-related documents.

Secure Delivery of Test Results: The vendor claims that NX Pro LIMS allows laboratories to securely communicate test results to patients through a web application. Patients can conveniently receive, store, and share their COVID-19 test results at any time and from anywhere. Each test result includes a unique secure QR code for contactless validation, and the application facilitates the printing of test reports for easy retrieval.

Workplace Testing: According to the vendor, NX Pro LIMS supports workplace testing, enabling organizations to maintain records of the health and safety of their personnel and minimize the risk of infection spread within the workplace.

Mobile Testing: The vendor states that NX Pro LIMS facilitates the automation of mobile testing workflows, streamlining testing processes in communities, public health organizations, and neighborhoods. Mobile testing laboratories can be effortlessly set up in various locations, providing convenient access to COVID-19 testing for the public.

Schools & Universities Set Up: According to the vendor, NX Pro LIMS assists schools and universities in implementing efficient screening and testing systems to ensure a clean and safe environment for students and staff.

Clinics & Physician Office Labs (POLs): The vendor claims that NX Pro LIMS supports physician office labs in delivering fast and effective COVID-19 testing and monitoring. The system enables physicians to promptly test patients upon arrival at the lab, leading to early initiation of treatment and improved patient outcomes.